BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16832771)

  • 1. [ApoE genotype influences on efficacy and safety of thrombolytic treatment for ischemic stroke].
    Fernández-Cadenas I; Alvarez Sabín J; Molina CA; Ribó M; Rosell A; Penalba A; Ortega L; Montaner J
    Neurologia; 2006 May; 21(4):176-80. PubMed ID: 16832771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke.
    Fernández-Cadenas I; Molina CA; Alvarez-Sabín J; Ribó M; Penalba A; Ortega-Torres L; Delgado P; Quintana M; Rosell A; Montaner J
    Neurosci Lett; 2006 May; 398(3):167-71. PubMed ID: 16442232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
    Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
    Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
    Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
    J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
    Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
    J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
    Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A
    Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of apolipoprotein E polymorphism on renal transplantation.
    Cofán F; Cofan M; Rosich E; Campos B; Casals E; Zambon D; Ros E; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2217-8. PubMed ID: 17889142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.
    Fernandez-Cadenas I; Mendioroz M; Munuera J; Alvarez-Sabin J; Rovira A; Quiroga A; Corbeto N; Rubiera M; Delgado P; Rosell A; Ribó M; Molina CA; Montaner J
    Thromb Haemost; 2009 Oct; 102(4):759-64. PubMed ID: 19806263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.